Valerian is marketed as a calming agent. The evidence behind that claim is thinner than the shelf space it occupies.

The herb is better studied for sleep than for stress, and even the sleep data is modest. The small double-blind trials that have tested valerian against situational stress return weak, inconsistent signals. Some show a calming effect. Others show nothing. The body of research is not large enough, nor clean enough, to call the question settled. What survives scrutiny is a plausible mechanism rather than a proven outcome: valerenic acid, the active compound, interacts with the brain’s GABA system in a manner loosely analogous to benzodiazepines. A mechanism is not a result, and human trials have repeatedly failed to convert the one into the other.